메뉴 건너뛰기




Volumn 148, Issue 6, 2015, Pages 1517-1527

Pulmonary disease due to nontuberculous mycobacteria current state and new insights

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; GAMMA INTERFERON; INTERLEUKIN 12; MACROLIDE; PRASTERONE; RIFAMPICIN; VITAMIN D; ANTIINFECTIVE AGENT; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;

EID: 84949009152     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.15-0458     Document Type: Article
Times cited : (83)

References (59)
  • 1
    • 38349049323 scopus 로고    scopus 로고
    • Pulmonary disease due to nontuberculous mycobacteria
    • Glassroth J. Pulmonary disease due to nontuberculous mycobacteria. Chest. 2008;133(1):243-251.
    • (2008) Chest. , vol.133 , Issue.1 , pp. 243-251
    • Glassroth, J.1
  • 2
    • 0018080322 scopus 로고
    • PPD-tuberculin and PPD-Battey dual skin testing of hospital employees and medical students
    • 922
    • Pitchenik AE. PPD-tuberculin and PPD-Battey dual skin testing of hospital employees and medical students. South Med J. 1978; 71(8):917-918, 922.
    • (1978) South Med J. , vol.71 , Issue.8 , pp. 917-918
    • Pitchenik, A.E.1
  • 3
    • 33847050904 scopus 로고    scopus 로고
    • An official ATS/IDSA statement: Diagnosis treatment and prevention of nontuberculous myco-bacterial diseases [published correction appears in Am J Respir Crit Care Med. 2007;175(7): 744-745]
    • Grifth DE, Aksamit T, Brown-Elliott BA, et al; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous myco-bacterial diseases [published correction appears in Am J Respir Crit Care Med. 2007;175(7):744-745]. Am J Respir Crit Care Med. 2007;175(4):367-416.
    • (2007) Am J Respir Crit Care Med. , vol.175 , Issue.4 , pp. 367-416
    • Grifth, D.E.1    Aksamit, T.2    Brown-Elliott, B.A.3
  • 4
    • 77958175715 scopus 로고    scopus 로고
    • Nontuberculous mycobac-terial lung disease prevalence at four integrated health care delivery systems
    • Prevots DR, Shaw PA, Strickland D, et al. Nontuberculous mycobac-terial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010;182(7):970-976.
    • (2010) Am J Respir Crit Care Med. , vol.182 , Issue.7 , pp. 970-976
    • Prevots, D.R.1    Shaw, P.A.2    Strickland, D.3
  • 5
    • 70349970665 scopus 로고    scopus 로고
    • Nontuberculous mycobacteria-associated lung disease in hospitalized persons United States 1998-2005
    • Billinger ME, Olivier KN, Viboud C, et al. Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005. Emerg Infect Dis. 2009;15(10):1562-1569.
    • (2009) Emerg Infect Dis. , vol.15 , Issue.10 , pp. 1562-1569
    • Billinger, M.E.1    Olivier, K.N.2    Viboud, C.3
  • 8
    • 41349117412 scopus 로고    scopus 로고
    • Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients Israel
    • Levy I, Grisaru-Soen G, Lerner-Geva L, et al. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis. 2008;14(3):378-384.
    • (2008) Emerg Infect Dis. , vol.14 , Issue.3 , pp. 378-384
    • Levy, I.1    Grisaru-Soen, G.2    Lerner-Geva, L.3
  • 9
    • 77649148255 scopus 로고    scopus 로고
    • Nontuberculous pulmonary mycobacteriosis in Denmark: Incidence and prognostic factors
    • Andréjak C, Tomsen VO, Johansen IS, et al. Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med. 2010;181(5):514-521.
    • (2010) Am J Respir Crit Care Med. , vol.181 , Issue.5 , pp. 514-521
    • Andréjak, C.1    Tomsen, V.O.2    Johansen, I.S.3
  • 10
    • 84908146256 scopus 로고    scopus 로고
    • Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: Screening practices and environmental risk
    • Adjemian J, Olivier KN, Prevots DR. Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk. Am J Respir Crit Care Med. 2014;190(5):581-586.
    • (2014) Am J Respir Crit Care Med. , vol.190 , Issue.5 , pp. 581-586
    • Adjemian, J.1    Olivier, K.N.2    Prevots, D.R.3
  • 12
    • 79952320659 scopus 로고    scopus 로고
    • Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease
    • Falkinham JO III. Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease. Emerg Infect Dis. 2011;17(3):419-424.
    • (2011) Emerg Infect Dis. , vol.17 , Issue.3 , pp. 419-424
    • Falkinham, J.O.1
  • 13
    • 0036737906 scopus 로고    scopus 로고
    • Pathogenesis of nontuberculous myco-bacteria infections
    • McGarvey J, Bermudez LE. Pathogenesis of nontuberculous myco-bacteria infections. Clin Chest Med. 2002;23(3):569-583.
    • (2002) Clin Chest Med. , vol.23 , Issue.3 , pp. 569-583
    • McGarvey, J.1    Bermudez, L.E.2
  • 14
    • 0033826812 scopus 로고    scopus 로고
    • Interferon-gamma and interleukin-12 pathway defects and human disease
    • Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev. 2000;11(4):321-333.
    • (2000) Cytokine Growth Factor Rev. , vol.11 , Issue.4 , pp. 321-333
    • Dorman, S.E.1    Holland, S.M.2
  • 15
    • 49649083344 scopus 로고    scopus 로고
    • Susceptibility to nontuberculous mycobac-terial lung disease
    • Sexton P, Harrison AC. Susceptibility to nontuberculous mycobac-terial lung disease. Eur Respir J. 2008;31(6):1322-1333.
    • (2008) Eur Respir J. , vol.31 , Issue.6 , pp. 1322-1333
    • Sexton, P.1    Harrison, A.C.2
  • 16
    • 84877584233 scopus 로고    scopus 로고
    • Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: A retrospective cohort study
    • Bryant JM, Grogono DM, Greaves D, et al. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet. 2013;381(9877):1551-1560.
    • (2013) Lancet. , vol.381 , Issue.9877 , pp. 1551-1560
    • Bryant, J.M.1    Grogono, D.M.2    Greaves, D.3
  • 17
    • 84855995836 scopus 로고    scopus 로고
    • Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center
    • Aitken ML, Limaye A, Pottinger P, et al. Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Am J Respir Crit Care Med. 2012;185(2): 231-232.
    • (2012) Am J Respir Crit Care Med. , vol.185 , Issue.2 , pp. 231-232
    • Aitken, M.L.1    Limaye, A.2    Pottinger, P.3
  • 18
    • 84894232053 scopus 로고    scopus 로고
    • High-level relatedness among Mycobacterium abscessus subsp massiliense strains from widely separated outbreaks
    • Tettelin H, Davidson RM, Agrawal S, et al. High-level relatedness among Mycobacterium abscessus subsp. massiliense strains from widely separated outbreaks. Emerg Infect Dis. 2014;20(3):364-371.
    • (2014) Emerg Infect Dis. , vol.20 , Issue.3 , pp. 364-371
    • Tettelin, H.1    Davidson, R.M.2    Agrawal, S.3
  • 19
    • 84867131448 scopus 로고    scopus 로고
    • Environment or host? A case-control study of risk factors for Mycobacterium avium complex lung disease
    • Dirac MA, Horan KL, Doody DR, et al. Environment or host? A case-control study of risk factors for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2012;186(7):684-691.
    • (2012) Am J Respir Crit Care Med. , vol.186 , Issue.7 , pp. 684-691
    • Dirac, M.A.1    Horan, K.L.2    Doody, D.R.3
  • 20
    • 57349187991 scopus 로고    scopus 로고
    • Pulmonary nontuberculous mycobacterial disease: Prospective study of a distinct preexisting syndrome
    • Kim RD, Greenberg DE, Ehrmantraut ME, et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med. 2008; 178 (10): 1066-1074.
    • (2008) Am J Respir Crit Care Med. , vol.178 , Issue.10 , pp. 1066-1074
    • Kim, R.D.1    Greenberg, D.E.2    Ehrmantraut, M.E.3
  • 21
    • 77949506650 scopus 로고    scopus 로고
    • Familial clustering of pulmonary nontuberculous mycobacterial disease
    • Colombo RE, Hill SC, Claypool RJ, Holland SM, Olivier KN. Familial clustering of pulmonary nontuberculous mycobacterial disease. Chest. 2010;137(3):629-634.
    • (2010) Chest. , vol.137 , Issue.3 , pp. 629-634
    • Colombo, R.E.1    Hill, S.C.2    Claypool, R.J.3    Holland, S.M.4    Olivier, K.N.5
  • 22
    • 84860576309 scopus 로고    scopus 로고
    • Lung manifestations in an autopsy-based series of pulmonary or disseminated nontuberculous mycobacterial disease
    • O'Connell ML, Birkenkamp KE, Kleiner DE, Folio LR, Holland SM, Olivier KN. Lung manifestations in an autopsy-based series of pulmonary or disseminated nontuberculous mycobacterial disease. Chest. 2012;141(4):1203-1209.
    • (2012) Chest. , vol.141 , Issue.4 , pp. 1203-1209
    • O'Connell, M.L.1    Birkenkamp, K.E.2    Kleiner, D.E.3    Folio, L.R.4    Holland, S.M.5    Olivier, K.N.6
  • 23
    • 78650213051 scopus 로고    scopus 로고
    • Vitamin D: Emerging roles in infection and immunity
    • Bartley J. Vitamin D: emerging roles in infection and immunity. Expert Rev Anti Infect Ther. 2010;8(12):1359-1369.
    • (2010) Expert Rev Anti Infect Ther. , vol.8 , Issue.12 , pp. 1359-1369
    • Bartley, J.1
  • 24
    • 84880789188 scopus 로고    scopus 로고
    • Severe Vitamin D def ciency is associated with non-tuberculous mycobacterial lung disease: A case-control study
    • Jeon K, Kim SY, Jeong BH, Chang B, Shin SJ, Koh WJ. Severe vitamin D def ciency is associated with non-tuberculous mycobacterial lung disease: a case-control study. Respirology. 2013;18(6):983-988.
    • (2013) Respirology. , vol.18 , Issue.6 , pp. 983-988
    • Jeon, K.1    Kim, S.Y.2    Jeong, B.H.3    Chang, B.4    Shin, S.J.5    Koh, W.J.6
  • 25
    • 84880278659 scopus 로고    scopus 로고
    • Modulation of the phenotype and function of Mycobacterium tuberculosis-stimulated dendritic cells by adrenal steroids
    • Angerami M, Suarez G, Pascutti MF, Salomon H, Bottasso O, Quiroga MF. Modulation of the phenotype and function of Mycobacterium tuberculosis-stimulated dendritic cells by adrenal steroids. Int Immunol. 2013;25(7):405-411.
    • (2013) Int Immunol. , vol.25 , Issue.7 , pp. 405-411
    • Angerami, M.1    Suarez, G.2    Pascutti, M.F.3    Salomon, H.4    Bottasso, O.5    Quiroga, M.F.6
  • 26
    • 0026091953 scopus 로고
    • Dehydroepian-drosterone enhances IL2 production and cytotoxic effector function of human T cells
    • Suzuki T, Suzuki N, Daynes RA, Engleman EG. Dehydroepian-drosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol. 1991; 61 (2): 202-211.
    • (1991) Clin Immunol Immunopathol. , vol.61 , Issue.2 , pp. 202-211
    • Suzuki, T.1    Suzuki, N.2    Daynes, R.A.3    Engleman, E.G.4
  • 28
    • 84879578236 scopus 로고    scopus 로고
    • Abnormal nasal nitric oxide production, ciliary beat frequency, and Toll-like receptor response in pulmonary nontuberculous mycobacterial disease epithelium
    • Fowler CJ, Olivier KN, Leung JM, et al. Abnormal nasal nitric oxide production, ciliary beat frequency, and Toll-like receptor response in pulmonary nontuberculous mycobacterial disease epithelium. Am J Respir Crit Care Med. 2013;187(12):1374-1381.
    • (2013) Am J Respir Crit Care Med. , vol.187 , Issue.12 , pp. 1374-1381
    • Fowler, C.J.1    Olivier, K.N.2    Leung, J.M.3
  • 29
    • 70349970943 scopus 로고    scopus 로고
    • Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy
    • Winthrop KL, Chang E, Yamashita S, Iademarco MF, LoBue PA. Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis. 2009;15(10):1556-1561.
    • (2009) Emerg Infect Dis. , vol.15 , Issue.10 , pp. 1556-1561
    • Winthrop, K.L.1    Chang, E.2    Yamashita, S.3    Iademarco, M.F.4    LoBue, P.A.5
  • 30
    • 84919779774 scopus 로고    scopus 로고
    • Risk factors for mortality in patients with pulmonary infections with non-tuberculous mycobac-teria: A retrospective cohort study
    • Gommans EP, Even P, Linssen CF, et al. Risk factors for mortality in patients with pulmonary infections with non-tuberculous mycobac-teria: a retrospective cohort study. Respir Med. 2015; 109 (1): 137-145.
    • (2015) Respir Med. , vol.109 , Issue.1 , pp. 137-145
    • Gommans, E.P.1    Even, P.2    Linssen, C.F.3
  • 31
    • 84891284715 scopus 로고    scopus 로고
    • Genetic diversity and phylogeny of Mycobacterium avium
    • Rindi L, Garzelli C. Genetic diversity and phylogeny of Mycobacterium avium. Infect Genet Evol. 2014;21:375-383.
    • (2014) Infect Genet Evol. , vol.21 , pp. 375-383
    • Rindi, L.1    Garzelli, C.2
  • 32
    • 77955422740 scopus 로고    scopus 로고
    • Comparative study for the virulence of Mycobacterium avium isolates from patients with nodular-bronchiectasis-and cavitary-type diseases
    • Tatano Y, Yasumoto K, Shimizu T, et al. Comparative study for the virulence of Mycobacterium avium isolates from patients with nodular-bronchiectasis-and cavitary-type diseases. Eur J Clin Microbiol Infect Dis. 2010;29(7):801-806.
    • (2010) Eur J Clin Microbiol Infect Dis. , vol.29 , Issue.7 , pp. 801-806
    • Tatano, Y.1    Yasumoto, K.2    Shimizu, T.3
  • 33
    • 84857304636 scopus 로고    scopus 로고
    • Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease
    • Ito Y, Hirai T, Maekawa K, et al. Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease. Int J Tuberc Lung Dis. 2012;16(3):408-414.
    • (2012) Int J Tuberc Lung Dis. , vol.16 , Issue.3 , pp. 408-414
    • Ito, Y.1    Hirai, T.2    Maekawa, K.3
  • 34
    • 0030938877 scopus 로고    scopus 로고
    • Pulmonary illness associated with exposure to Mycobacterium-avium complex in hot tub water. Hyper-sensitivity pneumonitis or infection?
    • Embil J, Warren P, Yakrus M, et al. Pulmonary illness associated with exposure to Mycobacterium-avium complex in hot tub water. Hyper-sensitivity pneumonitis or infection? Chest. 1997;111(3):813-816.
    • (1997) Chest. , vol.111 , Issue.3 , pp. 813-816
    • Embil, J.1    Warren, P.2    Yakrus, M.3
  • 35
    • 0035157897 scopus 로고    scopus 로고
    • Diffuse pulmonary disease caused by nontuberculous mycobacteria in immunocompetent people (hot tub lung)
    • Khoor A, Leslie KO, Tazelaar HD, Helmers RA, Colby TV. Diffuse pulmonary disease caused by nontuberculous mycobacteria in immunocompetent people (hot tub lung). Am J Clin Pathol. 2001; 115(5):755-762.
    • (2001) Am J Clin Pathol. , vol.115 , Issue.5 , pp. 755-762
    • Khoor, A.1    Leslie, K.O.2    Tazelaar, H.D.3    Helmers, R.A.4    Colby, T.V.5
  • 36
    • 33744502604 scopus 로고    scopus 로고
    • Hypersensitivity pneumonitis due to metal working fluids: Sporadic or under reported?
    • Gupta A, Rosenman KD. Hypersensitivity pneumonitis due to metal working fluids: sporadic or under reported? Am J Ind Med. 2006;49(6):423-433.
    • (2006) Am J Ind Med. , vol.49 , Issue.6 , pp. 423-433
    • Gupta, A.1    Rosenman, K.D.2
  • 37
    • 79951667398 scopus 로고    scopus 로고
    • Clinical symptoms and survival in non-smoking and smoking HIV-negative patients with non-tuberculous mycobacte-rial isolation
    • Kotilainen H, Valtonen V, Tukiainen P, Poussa T, Eskola J, Järvinen A. Clinical symptoms and survival in non-smoking and smoking HIV-negative patients with non-tuberculous mycobacte-rial isolation. Scand J Infect Dis. 2011;43(3):188-196.
    • (2011) Scand J Infect Dis. , vol.43 , Issue.3 , pp. 188-196
    • Kotilainen, H.1    Valtonen, V.2    Tukiainen, P.3    Poussa, T.4    Eskola, J.5    Järvinen, A.6
  • 38
    • 70350102842 scopus 로고    scopus 로고
    • Pulmonary Mycobacterium xenopi infection in non-HIV-infected patients: A systematic review
    • Varadi RG, Marras TK. Pulmonary Mycobacterium xenopi infection in non-HIV-infected patients: a systematic review. Int J Tuberc Lung Dis. 2009;13(10):1210-1218.
    • (2009) Int J Tuberc Lung Dis. , vol.13 , Issue.10 , pp. 1210-1218
    • Varadi, R.G.1    Marras, T.K.2
  • 40
    • 84929497999 scopus 로고    scopus 로고
    • The signif cance of Mycobacterium abscessus subspecies abscessus isolation during Mycobacterium avium complex lung disease therapy
    • Grifth DE, Philley JV, Brown-Elliott BA, et al. The signif cance of Mycobacterium abscessus subspecies abscessus isolation during Mycobacterium avium complex lung disease therapy. Chest. 2015; 147(5):1369-1375.
    • (2015) Chest. , vol.147 , Issue.5 , pp. 1369-1375
    • Grifth, D.E.1    Philley, J.V.2    Brown-Elliott, B.A.3
  • 41
    • 84893458487 scopus 로고    scopus 로고
    • Clinical signif cance of a first positive nontuberculous mycobacteria culture in cystic fbrosis
    • Martiniano SL, Sontag MK, Daley CL, Nick JA, Sagel SD. Clinical signif cance of a first positive nontuberculous mycobacteria culture in cystic fbrosis. Ann Am Thorac Soc. 2014;11(1):36-44.
    • (2014) Ann Am Thorac Soc. , vol.11 , Issue.1 , pp. 36-44
    • Martiniano, S.L.1    Sontag, M.K.2    Daley, C.L.3    Nick, J.A.4    Sagel, S.D.5
  • 44
    • 84868285088 scopus 로고    scopus 로고
    • Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance
    • Choi GE, Shin SJ, Won CJ, et al. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. Am J Respir Crit Care Med. 2012;186(9):917-925.
    • (2012) Am J Respir Crit Care Med. , vol.186 , Issue.9 , pp. 917-925
    • Choi, G.E.1    Shin, S.J.2    Won, C.J.3
  • 45
    • 84898491164 scopus 로고    scopus 로고
    • Detection of Mycobacterium avium complex DNA directly in clinical respiratory specimens: Opportunities for improved turn-around time and cost savings
    • Tran AC, Halse TA, Escuyer VE, Musser KA. Detection of Mycobacterium avium complex DNA directly in clinical respiratory specimens: opportunities for improved turn-around time and cost savings. Diagn Microbiol Infect Dis. 2014;79(1):43-48.
    • (2014) Diagn Microbiol Infect Dis. , vol.79 , Issue.1 , pp. 43-48
    • Tran, A.C.1    Halse, T.A.2    Escuyer, V.E.3    Musser, K.A.4
  • 46
    • 84865125784 scopus 로고    scopus 로고
    • Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period
    • Kobashi Y, Abe M, Mouri K, Obase Y, Kato S, Oka M. Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period. J Infect Chemother. 2012;18(4):436-443.
    • (2012) J Infect Chemother. , vol.18 , Issue.4 , pp. 436-443
    • Kobashi, Y.1    Abe, M.2    Mouri, K.3    Obase, Y.4    Kato, S.5    Oka, M.6
  • 47
    • 84884741628 scopus 로고    scopus 로고
    • In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates
    • Brown-Elliott BA, Iakhiaeva E, Grifth DE, et al. In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates. J Clin Microbiol. 2013; 51 (10): 3389-3394.
    • (2013) J Clin Microbiol. , vol.51 , Issue.10 , pp. 3389-3394
    • Brown-Elliott, B.A.1    Iakhiaeva, E.2    Grifth, D.E.3
  • 48
    • 77958172574 scopus 로고    scopus 로고
    • Pulmonary nontu-berculous mycobacterial disease prevalence and clinical features: An emerging public health disease
    • Winthrop KL, McNelley E, Kendall B, et al. Pulmonary nontu-berculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med. 2010;182(7):977-982.
    • (2010) Am J Respir Crit Care Med. , vol.182 , Issue.7 , pp. 977-982
    • Winthrop, K.L.1    McNelley, E.2    Kendall, B.3
  • 49
    • 84893452777 scopus 로고    scopus 로고
    • Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease
    • Adjemian J, Prevots DR, Gallagher J, Heap K, Gupta R, Griffth D. Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease. Ann Am Thorac Soc. 2014;11(1):9-16.
    • (2014) Ann Am Thorac Soc. , vol.11 , Issue.1 , pp. 9-16
    • Adjemian, J.1    Prevots, D.R.2    Gallagher, J.3    Heap, K.4    Gupta, R.5    Griffth, D.6
  • 50
    • 0031868612 scopus 로고    scopus 로고
    • Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodef ciency virus-negative patients
    • Griffth DE, Brown BA, Murphy DT, Girard WM, Couch L, Wallace RJ Jr. Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodef ciency virus-negative patients. J Infect Dis. 1998;178(1):121-126.
    • (1998) J Infect Dis. , vol.178 , Issue.1 , pp. 121-126
    • Grifth, D.E.1    Brown, B.A.2    Murphy, D.T.3    Girard, W.M.4    Couch, L.5    Wallace, R.J.6
  • 51
    • 0034096449 scopus 로고    scopus 로고
    • Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex
    • Griffth DE, Brown BA, Cegielski P, Murphy DT, Wallace RJ Jr. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex. Clin Infect Dis. 2000;30(2):288-292.
    • (2000) Clin Infect Dis. , vol.30 , Issue.2 , pp. 288-292
    • Grifth, D.E.1    Brown, B.A.2    Cegielski, P.3    Murphy, D.T.4    Wallace, R.J.5
  • 52
    • 84920457768 scopus 로고    scopus 로고
    • Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease
    • Jeong BH, Jeon K, Park HY, et al. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2015;191(1):96-103.
    • (2015) Am J Respir Crit Care Med. , vol.191 , Issue.1 , pp. 96-103
    • Jeong, B.H.1    Jeon, K.2    Park, H.Y.3
  • 53
    • 84902109958 scopus 로고    scopus 로고
    • Macrolide/azalide therapy for nodular/bronchiectatic Mycobacterium avium complex lung disease
    • Wallace RJ Jr, Brown-Elliott BA, McNulty S, et al. Macrolide/azalide therapy for nodular/bronchiectatic Mycobacterium avium complex lung disease. Chest. 2014;146(2):276-282.
    • (2014) Chest. , vol.146 , Issue.2 , pp. 276-282
    • Wallace, R.J.1    Brown-Elliott, B.A.2    McNulty, S.3
  • 54
    • 79551545950 scopus 로고    scopus 로고
    • Clinical signif cance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus
    • Koh WJ, Jeon K, Lee NY, et al. Clinical signif cance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med. 2011;183(3):405-410.
    • (2011) Am J Respir Crit Care Med. , vol.183 , Issue.3 , pp. 405-410
    • Koh, W.J.1    Jeon, K.2    Lee, N.Y.3
  • 55
    • 84861320034 scopus 로고    scopus 로고
    • Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy
    • Kim HS, Lee KS, Koh WJ, et al. Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy. Radiology. 2012;263(1):260-270.
    • (2012) Radiology. , vol.263 , Issue.1 , pp. 260-270
    • Kim, H.S.1    Lee, K.S.2    Koh, W.J.3
  • 56
    • 84866410786 scopus 로고    scopus 로고
    • The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment
    • van Ingen J, Egelund EF, Levin A, et al. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment. Am J Respir Crit Care Med. 2012;186(6): 559-565.
    • (2012) Am J Respir Crit Care Med. , vol.186 , Issue.6 , pp. 559-565
    • Van Ingen, J.1    Egelund, E.F.2    Levin, A.3
  • 57
    • 84893507930 scopus 로고    scopus 로고
    • Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease
    • Olivier KN, Shaw PA, Glaser TS, et al. Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease. Ann Am Thorac Soc. 2014;11(1):30-35.
    • (2014) Ann Am Thorac Soc. , vol.11 , Issue.1 , pp. 30-35
    • Olivier, K.N.1    Shaw, P.A.2    Glaser, T.S.3
  • 58
    • 84939229750 scopus 로고    scopus 로고
    • Preliminary results of bedaquiline as salvage therapy for patients with nontuberculous mycobacterial lung disease
    • Philley JV, Wallace RJ Jr, Benwill JL, et al. Preliminary results of bedaquiline as salvage therapy for patients with nontuberculous mycobacterial lung disease. Chest. 2015;148(2):499-506.
    • (2015) Chest. , vol.148 , Issue.2 , pp. 499-506
    • Philley, J.V.1    Wallace, R.J.2    Benwill, J.L.3
  • 59
    • 84885183409 scopus 로고    scopus 로고
    • Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fbrosis
    • Binder AM, Adjemian J, Olivier KN, Prevots DR. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fbrosis. Am J Respir Crit Care Med. 2013;188(7):807-812.
    • (2013) Am J Respir Crit Care Med. , vol.188 , Issue.7 , pp. 807-812
    • Binder, A.M.1    Adjemian, J.2    Olivier, K.N.3    Prevots, D.R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.